Example: Heart Attack

Clinical Trials on Urologic Neoplasms

Total 2697 results

NCT02281188

Active, not recruiting

Registry for Treatment of Upper Urinary Tract Tumours

Conditions: Upper Urinary Tract Tumours
NCT04052113

Completed

Real World Evidence of PD-L1, TMB Prevalence and Efficacy of 1st Line Chemotherapy in These High or Low Population for Stage IV Urothelial Cancer

Conditions: Urologic Neoplasms
NCT04649970

Completed

Antegrade Double-J Stent Placement for the Treatment of Malignant Obstructive Uropathy

Conditions: Urologic Neoplasms
NCT02780687

Completed

Afatinib Monotherapy in Patients With ERBB-deregulated Metastatic Urothelial Tract Carcinoma After Failure of Platinum Based Chemotherapy

Conditions: Urologic Neoplasms
NCT00350025

Completed

Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer

Conditions: Urologic Neoplasm
NCT00374868

Completed

Pemetrexed Plus Cisplatin Bi-Weekly, in Patients With Urothelial Cancer (Metastatic, Locally Advanced or Non-Resectable)

Conditions: Urologic Neoplasms
NCT00151034

Completed

Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer

Conditions: Urologic Neoplasms
NCT00226954

Terminated

Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer

Conditions: Urologic Neoplasms
NCT00034177

Completed

Safety and Efficacy of S-8184 in Treatment of Locally Advanced, Metastatic, or Recurrent TCC of the Urothelium

Conditions: Urologic Neoplasms
NCT00034593

Completed

A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

Conditions: Urologic Neoplasms
NCT04207463

Recruiting

A Study of Anlotinib and AK105 Injection in Subjects With Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors

Conditions: Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors
NCT04702347

Recruiting

Genetic Testing in Upper Tract Urothelial Carcinoma (UTUC): the Epicheck Study

Conditions: Urologic Cancer; Urologic Neoplasms
NCT03204266

Active, not recruiting

Oral Supplementation to Enhance Recovery Pilot Study

Conditions: Malignant Neoplasms of Urinary Tract
NCT04630483

Recruiting

Platelet-lymphocyte and Neutrophil-lymphocyte Ratio in Patients Undergoing Cancer Surgery

Conditions: Cancer; Urologic Neoplasms; Gynecologic Cancer
NCT00191971

Completed

2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP Regimen

Conditions: Urologic Neoplasms; Carcinoma, Transitional Cell
NCT00001814

Completed

Genetic Analysis of Inherited Urologic Malignant Disorders: Collection of Samples

Conditions: Neoplastic Syndromes, Hereditary; Urologic Neoplasms
NCT00035061

Completed

A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium

Conditions: Urologic Neoplasms; Metastases, Neoplasm
NCT01454089

Completed

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Conditions: Urologic Neoplasms; Metastatic Bladder Cancer; Urinary Tract Neoplasms
NCT02276924

Completed

Diagnostic Relevance of Laser Confocal Microscopy for the Screening of Upper Urinary Tract Tumors

Conditions: Hematuria; Nephrolithiasis; Cancer of Urinary Tract; Ureteropelvic Junction Obstruction
NCT03138967

Completed

Investigation of Sugammadex in Outpatient Urological Procedures

Conditions: Malignant Neoplasms of Urinary Tract; Bladder Cancer
NCT01155791

Terminated

Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer

Conditions: Urologic Neoplasms; Prostate Cancer; Prostate Cancer Metastatic Disease
NCT03595813

Recruiting

Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer Immunotherapy

Conditions: Lung Cancer Metastatic; Locally Advanced Malignant Neoplasm; Non Hodgkin Lymphoma; Urologic Neoplasms
NCT04720599

Recruiting

Clinical Evaluation of ExoDx Prostate(IntelliScore) in Men Presenting for Initial Prostate Biopsy

Conditions: Urologic Cancer
NCT02836795

Active, not recruiting

Safety and Tolerability of Recombinant Humanized Anti-PD-1 Monoclonal Antibody Toripalimab for Patients With Advanced Solid Tumors

Conditions: Melanoma; Urological Cancer
NCT03548688

Completed

Investigation and Detection of Urological Neoplasia in Patients Referred With Suspected Urinary Tract Cancer:

Conditions: Urothelial Carcinoma